Browsing by Subject "Chronic Disease"

Now showing 1 - 8 of 8
  • Thumbnail Image
    Item
    B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality
    (Nature Publishing Group, 2017-07) Saliba, R.M.; Sarantopoulos, S.; Kitko, C.L.; Pawarode, A.; Goldstein, S.C.; Magenau, J.; Alousi, A.M.; Churay, T.; Justman, H.; Paczesny, Sophie; Reddy, P.; Couriel, D.R.; Pediatrics, School of Medicine
    Biological markers for risk stratification of chronic GvHD (cGvHD) could improve the care of patients undergoing allogeneic hematopoietic stem cell transplantation. Increased plasma levels of B-cell activating factor (BAFF), chemokine (C-X-C motif) ligand 9 (CXCL9) and elafin have been associated with the diagnosis, but not with outcome in patients with cGvHD. We evaluated the association between levels of these soluble proteins, measured by ELISA at the time of cGvHD diagnosis and before the initiation of therapy, with non-relapse-mortality (NRM). Based on the log-transformed values, factor levels were divided into tertiles defined respectively as low, intermediate, and high levels. On univariable analysis, BAFF levels were significantly associated with NRM, whereas CXCL9 and elafin levels were not. Both low (⩽2.3 ng/mL, hazard ratio (HR)=5.8, P=0.03) and high (>5.7 ng/mL, HR=5.4, P=0.03) BAFF levels were associated with a significantly higher NRM compared with intermediate BAFF level. The significant effect of high or low BAFF levels persisted in multivariable analysis. A subset of cGvHD patients had persistently low BAFF levels. In conclusion, our data show that BAFF levels at the time of cGvHD diagnosis are associated with NRM, and also are potentially useful for risk stratification. These results warrant confirmation in larger studies.
  • Thumbnail Image
    Item
    Electronic Health Record (EHR) Data Quality and Type 2 Diabetes Mellitus Care
    (2022-06) Wiley, Kevin Keith, Jr.; Vest, Joshua; Blackburn, Justin; De Groot, Mary; Menachemi, Nir; Mendonca, Eneida
    Due to frequent utilization, high costs, high prevalence, and negative health outcomes, the care of patients managing type 2 diabetes mellitus (T2DM) remains an important focus for providers, payers, and policymakers. The challenges of care delivery, including care fragmentation, reliance on patient self-management behaviors, adherence to care management plans, and frequent medical visits are well-documented in the literature. T2DM management produces numerous clinical data points in the electronic health record (EHR) including laboratory test values and self-reported behaviors. Recency or absence of these data may limit providers’ ability to make effective treatment decisions for care management. Increasingly, the context in which these data are being generated is changing. Specifically, telehealth usage is increasing. Adoption and use of telehealth for outpatient care is part of a broader trend to provide care at-a-distance, which was further accelerated by the COVID-19 pandemic. Despite unknown implications for patients managing T2DM, providers are increasingly using telehealth tools to complement traditional disease management programs and have adapted documentation practices for virtual care settings. Evidence suggests the quality of data documented during telehealth visits differs from that which is documented during traditional in-person visits. EHR data of differential quality could have cascading negative effects on patient healthcare outcomes. The purpose of this dissertation is to examine whether and to what extent levels of EHR data quality are associated with healthcare outcomes and if EHR data quality is improved by using health information technologies. This dissertation includes three studies: 1) a cross-sectional analysis that quantifies the extent to which EHR data are timely, complete, and uniform among patients managing T2DM with and without a history of telehealth use; 2) a panel analysis to examine associations between primary care laboratory test ages (timeliness) and subsequent inpatient hospitalizations and emergency department admissions; and 3) a panel analysis to examine associations between patient portal use and EHR data timeliness.
  • Thumbnail Image
    Item
    Examining Health Behaviors of Chronic Disease Caregivers in the U.S.
    (Elsevier, 2022-03) Secinti, Ekin; Wu, Wei; Kent, Erin E.; Demark-Wahnefried, Wendy; Lewson, Ashley B.; Mosher, Catherine E.; Psychology, School of Science
    INTRODUCTION: Many informal caregivers experience a significant caregiving burden, which may interfere with their health behaviors. Caregiver health behaviors may vary by disease context, but this has rarely been studied. This study compares the health behaviors of prevalent groups of chronic illness caregivers (i.e., dementia, cancer, chronic obstructive pulmonary disease/emphysema, diabetes) with those of noncaregivers and examines whether caregiving intensity is associated with these behaviors. METHODS: In 2021, using pooled cross-sectional 2015-2019 Behavioral Risk Factor Surveillance System data, health behaviors (i.e., physical activity, diet, alcohol use, smoking, sleep, and influenza immunization) of caregivers of patients with dementia (n=5,525), cancer (n=4,246), chronic obstructive pulmonary disease/emphysema (n=1,959), and diabetes (n=2,853) and noncaregivers (n=203,848) were compared. Relationships between caregiving intensity (e.g., hours, type of tasks) and caregiver health behaviors were examined. Regression analyses were used to compare groups. RESULTS: Compared with noncaregivers, caregiver groups were more likely to report engaging in both risky (i.e., smoking, shorter sleep duration) and health-promoting (i.e., physical activity, vegetable consumption, abstaining from heavy drinking) behaviors, whereas nonsignificant differences were observed for influenza immunization. Longer caregiving hours and providing help with personal care were associated with poorer health behaviors (e.g., shorter sleep duration). Few differences in health behaviors were observed between caregivers of patients with dementia and other caregiver groups. CONCLUSIONS: Results suggest that caregivers are more likely to engage in both risky and health-promoting behaviors than noncaregivers. Furthermore, findings suggest that greater caregiving responsibilities are associated with certain risky health behaviors. Findings support the development and implementation of strategies to improve caregivers' health behaviors across disease contexts.
  • Thumbnail Image
    Item
    Implications for Training on Smartphone Medication Reminder App Use by Adults With Chronic Conditions: Pilot Study Applying the Technology Acceptance Model
    (JMIR, 2017) Park, Daniel Y.; Goering, Elizabeth M.; Head, Katharine J.; Bartlett Ellis, Rebecca J.; School of Nursing
    Background: The majority of middle-aged to older patients with chronic conditions report forgetting to take medications as prescribed. The promotion of patients’ smartphone medication reminder app (SMRA) use shows promise as a feasible and cost-effective way to support their medication adherence. Providing training on SMRA use, guided by the technology acceptance model (TAM), could be a promising intervention to promote patients’ app use. Objective: The aim of this pilot study was to (1) assess the feasibility of an SMRA training session designed to increase patients’ intention to use the app through targeting perceived usefulness of app, perceived ease of app use, and positive subjective norm regarding app use and (2) understand the ways to improve the design and implementation of the training session in a hospital setting. Methods: A two-group design was employed. A total of 11 patients older than 40 years (median=58, SD=9.55) and taking 3 or more prescribed medications took part in the study on one of two different dates as participants in either the training group (n=5) or nontraining group (n=6). The training group received an approximately 2-hour intervention training session designed to target TAM variables regarding one popular SMRA, the Medisafe app. The nontraining group received an approximately 2-hour control training session where the participants individually explored Medisafe app features. Each training session was concluded with a one-time survey and a one-time focus group. Results: Mann-Whitney U tests revealed that the level of perceived ease of use (P=.13) and the level of intention to use an SMRA (P=.33) were higher in the training group (median=7.00, median=6.67, respectively) than in the nontraining group (median=6.25, median=5.83). However, the level of perceived usefulness (U=4.50, Z=−1.99, P=.05) and the level of positive subjective norm (P=.25) were lower in the training group (median=6.50, median=4.29) than in the nontraining group (median=6.92, median=4.50). Focus groups revealed the following participants’ perceptions of SMRA use in the real-world setting that the intervention training session would need to emphasize in targeting perceived usefulness and positive subjective norm: (1) the participants would find an SMRA to be useful if they thought the app could help address specific struggles in medication adherence in their lives and (2) the participants think that their family members (or health care providers) might view positively the participants’ SMRA use in primary care settings (or during routine medical checkups). Conclusions: Intervention training session, guided by TAM, appeared feasible in targeting patients’ perceived ease of use and, thereby, increasing intention to use an SMRA. Emphasizing the real-world utility of SMRA, the training session could better target patients’ perceived usefulness and positive subjective norm that are also important in increasing their intention to use the app. [JMIR Formativ Res 2017;1(1):e5]
  • Thumbnail Image
    Item
    Induction of chronic migraine phenotypes in a rat model after environmental irritant exposure
    (Lippincott, Williams & Wilkins, 2018-03) Kunkler, Phillip Edward; Zhang, LuJuan; Johnson, Philip Lee; Oxford, Gerry Stephen; Hurley, Joyce Harts; Biochemistry and Molecular Biology, School of Medicine
    Air pollution is linked to increased emergency department visits for headache and migraine patients frequently cite chemicals or odors as headache triggers, but the association between air pollutants and headache is not well understood. We previously reported that chronic environmental irritant exposure sensitizes the trigeminovascular system response to nasal administration of environmental irritants. Here, we examine whether chronic environmental irritant exposure induces migraine behavioral phenotypes. Male rats were exposed to acrolein, a transient receptor potential channel ankyrin-1 (TRPA1) agonist, or room air by inhalation for 4 days before meningeal blood flow measurements, periorbital cutaneous sensory testing, or other behavioral testing. Touch-induced c-Fos expression in trigeminal nucleus caudalis was compared in animals exposed to room air or acrolein. Spontaneous behavior and olfactory discrimination was examined in open-field testing. Acrolein inhalation exposure produced long-lasting potentiation of blood flow responses to a subsequent TRPA1 agonist and sensitized cutaneous responses to mechanical stimulation. C-Fos expression in response to touch was increased in trigeminal nucleus caudalis in animals exposed to acrolein compared with room air. Spontaneous activity in an open-field and scent preference behavior was different in acrolein-exposed compared with room air-exposed animals. Sumatriptan, an acute migraine treatment blocked acute blood flow changes in response to TRPA1 or transient receptor potential vanilloid receptor-1 agonists. Pretreatment with valproic acid, a prophylactic migraine treatment, attenuated the enhanced blood flow responses observed after acrolein inhalation exposures. Environmental irritant exposure yields an animal model of chronic migraine in which to study mechanisms for enhanced headache susceptibility after chemical exposure.
  • Thumbnail Image
    Item
    Interprofessionality: A Pathway to a More Sustainable National Healthcare System
    (IGI Global, 2020-02-07) Obichi, Chidiebele Constance; Newton, April D.; Oruche, Ukamaka M.
    Preventable medical errors (PME) is the third leading cause of death in the United States with an incidence range of 210,000 to 400,000 deaths per year and an estimated cost of $19.5 billion to $958 billion per year. Despite advances in patient safety, PME persists across the nation.
  • Thumbnail Image
    Item
    The Relationship Between Instrumental Activities of Daily Living and Hospitalizations: A Systematic Review and Meta-Analysis
    (2024-07) Collins, Jason Joseph; Newhouse, Robin P.; Levoy, Krisin; Basile, David P.; Jung, Miyeon
    Instrumental activities of daily living (IADL) have been defined as the activities for which their performance is necessary for continued independent living arrangements and that are more complex than routine activities of daily living. Evidence has reported the presence of IADL impairments in patients discharging from hospital. However, there is little research evaluating the role of IADLs as a modifiable risk factor in preventing hospitalizations among high-risk groups, such as heart failure. This oversight leaves gaps in discharge planning, in connecting patients to needed services that address impaired IADLs. The purpose of this dissertation was to improve knowledge of the relationship between IADLs and hospitalizations by: 1) describing the theory that underpins the relationship between IADLs and hospitalizations; 2) completing a systematic review to narratively synthesize the state of use of IADL scales across studies examining hospitalizations among high-risk groups (i.e., heart failure); 3) completing a meta-analysis to estimate the overall association between IADLs and hospitalizations among the high-risk groups; 4) conducting tests of moderation using meta-analytic techniques to determine whether the overall association between IADLs and hospitalizations varied based on certain IADL scale characteristics (e.g., number of components). Founded upon the Theory of Self-Care of Chronic Illness, the systematic search produced 4,932 articles, with 23 meeting criteria. The systematic review revealed that IADL discussions have been present in healthcare literature internationally since 1969; significant heterogeneity exists in the number of IADL components; the legacy work of Lawton and Brody (1969) remains prevalent but not panoptic; and IADLs have been studied in a wide variety of illnesses. The meta-analysis revealed that IADL impairments were positively associated with hospitalizations (OR=1.40, 95% CI: 1.24, 1.58; k=22, p<.001). Tests of moderation indicated that the IADL scale (QM=0.496, p=0.481) and item composition (QM=0.189, p=0.664) did not explain variation among effect sizes, indicating that the IADL scale formulation did not impact the relationship between IADLs deficits and hospitalizations. This dissertation provides compelling evidence that assessing IADLs may yield a significant opportunity to identify modifiable risk factors to reduce hospitalization. More work is needed to standardize IADL measurement at discharge to identify patients at high risk.
  • Thumbnail Image
    Item
    Transcriptional repression by ApiAP2 factors is central to chronic toxoplasmosis
    (Public Library of Science, 2018-05-02) Radke, Joshua B.; Worth, Danielle; Hong, David; Huang, Sherri; Sullivan, William J., Jr.; Wilson, Emma H.; White, Michael W.; Pharmacology and Toxicology, School of Medicine
    Tachyzoite to bradyzoite development in Toxoplasma is marked by major changes in gene expression resulting in a parasite that expresses a new repertoire of surface antigens hidden inside a modified parasitophorous vacuole called the tissue cyst. The factors that control this important life cycle transition are not well understood. Here we describe an important transcriptional repressor mechanism controlling bradyzoite differentiation that operates in the tachyzoite stage. The ApiAP2 factor, AP2IV-4, is a nuclear factor dynamically expressed in late S phase through mitosis/cytokinesis of the tachyzoite cell cycle. Remarkably, deletion of the AP2IV-4 locus resulted in the expression of a subset of bradyzoite-specific proteins in replicating tachyzoites that included tissue cyst wall components BPK1, MCP4, CST1 and the surface antigen SRS9. In the murine animal model, the mis-timing of bradyzoite antigens in tachyzoites lacking AP2IV-4 caused a potent inflammatory monocyte immune response that effectively eliminated this parasite and prevented tissue cyst formation in mouse brain tissue. Altogether, these results indicate that suppression of bradyzoite antigens by AP2IV-4 during acute infection is required for Toxoplasma to successfully establish a chronic infection in the immune-competent host.